Ejlertsen, B <br/><br/>
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2012 
 - 1138-1144 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr438  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--diagnosis<br/>Carcinoma--diagnosis<br/>Cohort Studies<br/>Denmark<br/>Estrogen Receptor alpha--analysis<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Postmenopause--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome